Patient fatality reported in clinical trial for investigational gene therapy for Danon disease.

Mistakes in fill-finish can lead to lost batches, lost profits, and increased regulatory scrutiny. Four experts discuss.

From bird flu to COVID-19 vaccines to alleged corruption in journals, we look into recent moves from US Health Secretary RFK Jr.

From different modalities to overcoming aggregation; we find out what advances are affecting the development of ADCs.

Our latest news roundup reports on a new blow for Harvard, how Pfizer and Astellas’ Xtandi improves cancer survival, and more.

We ask a company about lessons learned from the GMP certification process.

Our latest news roundup reports on a gene therapy for Duchenne muscular dystrophy that can be re-dosed, a free toolkit for gene delivery, and more.

A report attempts to unravel the many challenges that face business leaders. We discuss those inherent in the pharmaceutical industry.

The development of CAR T-cell technology is a defining moment in the history of biomedicine – one of the all-time amazing transformative breakthroughs

Researchers conduct small phase I study on placenta-derived stem cell therapy to treat a serious form of multiple sclerosis